DGAP-Adhoc: Erling Haaland close to move to Manchester City
2022. május 10., kedd, 16:28
DGAP-Ad-hoc: Borussia Dortmund GmbH & Co. KGaA / Key word(s): Contract The player Erling Haaland ("Player") is close to move from Borussia Dortmund GmbH & Co. KGaA ("BVB") to Manchester City Football Club Limited („Manchester City“). This is the today´s mutual agreement in principle of all parties. The contractual details now have to be coordinated and completed. Moreover, the realization of the transfer is still subject to the proper and timely processing in accordance with the provisions of the FIFA Transfer Matching System (FIFA TMS). With the realization of this transfer deal, the management expects a positive effect on the key earnings figures (EBITDA, EBIT) for the 2022/2023 financial year in a range of approx. 35.0 - 40.0 m. EUR. Due to the opening of the FIFA international transfer window from July 1, 2022 onwards and other regulatory association requirements this transfer deal will not fall in the current 2021/2022 financial year, but in the 2022/2023 financial year.
Borussia Dortmund GmbH & Co. KGaA
Contact: Dr. Robin Steden Inhouse Counsel / Investor Relations
|
Language: | English |
Company: | Borussia Dortmund GmbH & Co. KGaA |
Rheinlanddamm 207 - 209 | |
44137 Dortmund | |
Germany | |
Phone: | 0231/ 90 20 - 2746 |
Fax: | 0231/ 90 20 - 852746 |
E-mail: | aktie@bvb.de |
Internet: | www.bvb.de/aktie // www.aktie.bvb.de |
ISIN: | DE0005493092 |
WKN: | 549309 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1348651 |
End of Announcement | DGAP News Service |
1348651 10-May-2022 CET/CEST
Közzétételek - archívum
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]